ARIAD stock surged 70+% on the news; Takeda posted a modest 6+% gain, and Valeant remained relatively unchanged. Investment Thesis(s) I) Valeant shareholders For Valeant shareholders, this news is moderately bad. I believe a Salix …
ARIAD Pharmaceuticals, Inc. ARIA remains focused on the discovery, development and commercialization of breakthrough treatments for cancer. This year was a tough one for the pharma sector, which had to grapple with media and political …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
StockConsultant.com - ARIA ($ARIA) Ariad Pharmaceuticals stock latest quote 10.67 +0.2,+1.9% has a new high breakout watch above 10.8. Full technical analysis and charts at http://chart.st/ARIA ARIA Stock Chart …
ARIAD Pharmaceuticals, Inc. ARIA is scheduled to report first-quarter 2016 results on May 10, before the opening bell. The company posted a negative earnings surprise of 14.29% in the fourth quarter of 2015. Let’s see how things are shaping …
ARIA stock had traded over $20 a share in September, but ARIA stock plunged in October after the U.S. Food and Drug Administration halted a trial of its anti-cancer treatment, Iclusig, after some patients developed blood clots. The buyers …
"He will stay for five days. It's a two-day competition over a five day period," Aria Honvou explained. I learned more of this art at Kotaku.com: "Like cowboys in the …
Local SourceThe Plain Dealer3h
The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer-focused ARIAD ARIA for a whopping $5.2 billion. Several other licensing deals and agreements were …
Once again, a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground on a tweet regarding the company’s price hikes for cancer drug, Iclusig. Meanwhile, Regeneron REGN suffered a pipeline …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the …